IHS Chemical Week

People & Business :: M&A

Swedish pharma group Meda to acquire Acton Pharmaceuticals

8:56 AM MDT | August 31, 2013 | Natasha Alperowicz

Lönner: A good fit. Meda (Solna, Sweden), a specialty pharma group, says it has signed a definitive agreement to acquire the development company Acton Pharmaceuticals (Marlborough, MA), including the proprietary product Aerospan, an inhaler for the treatment of asthma that contains the active substance flunisolide. The product has recently been approved by the FDA and has shown in clinical studies to have a high deposition of active drug in the airways as a result of a built-in inhalation chamber.   Under the terms of the transaction, Meda will acquire...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa